Over 130 HPV types have been documented in literature, approximately 40 of which infect the anogenital area and are sexually transmitted. Persistent anogenital high risk HPV infection is associated with the majority of cervical cancers. Cervical cancer is highly preventable when cytological and HPV screening programs are employed to facilitate early detection and treatment of pre-cancerous lesions. Of the sexually transmitted HPV genotypes, 14 (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) are considered high risk as they lead to cervical cancer or anogenital warts. In addition, HPV types 6 and 11 are considered low risk for cervical cancer, however they are the cause of 90% of all cases of genital warts as well as respiratory papillomatosis.
Rapid and precise analysis - From collected samples to results in less than 2hr
Quick and easy setup procedure - 20min of hands on time for evaluating 96 patient samples
No need for purchasing equipment - compatible with all current qPCR platforms (4 Fluorescent Channels)
Quality by Design - Flag samples with low cellularity through β-Actin internal control reducing false negative results
HPV Complete qPCR Kit
The GeneNav™ HPV Complete qPCR Kit is a single tube system which utilizes quantitative PCR (qPCR) technology to detect the 16 HPV types described. This kit is able to simultaneously detect the presence of HPV 16 or HPV 18, one of the other high risk HPV subtypes, and HPV 6 or 11.